Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$0.77 0.13 (20.86%)
2/9/2010 4:00 PM

Cell Therapeutics, Inc. (CTIC)

CAPS Rating:
***

The Company develops, acquires and commercializes novel treatments for cancer and focuses its research and in-licensing activities on identifying and developing new, less toxic and effective ways to treat cancer.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

Ticker Not Ratable

CTIC doesn't currently meet the $100M market cap / $1.50 stock price minimum. (Learn More)

What the Community Thinks

Total Members

209 Outperforms
22 Underperforms
 

All-Stars

50 Outperforms
8 Underperforms
 

Wall Street

1 Outperforms
0 Underperforms
 

Members bullish on CTIC are also bullish on:

Members bearish on CTIC are also bearish on:

Ticker Tags

Healthcare (711), Micro Cap (4701), Pharmaceuticals (149), Biotechnology (220), Rule Breakers Universe (125), Defensive (1457)
Suggest a tag

Cell Therapeutics, Inc. At A Glance

Current Price: $0.77
Last Trade Time: 2/9/2010 4:00 PM
Open: $0.00
Previous Close: $0.64
Daily Range: $0.74 - $0.80
52-Week Range: $0.05 - $2.23
Volume: 53,771,213
Market Cap: $444.32M
P/E Ratio: 0.10
Compare Our Special Broker Offers!

Stock Trends

CTIC VS S&P 500 (SPY)

News & Discussion Boards

Top Bull Pitch

Recs

2

Cell Therapeutics, Inc. (CTIC)

Avatar dbbfool63 (96.66) Submitted: 8/27/09 6:28 PM

Good entry point for mid to long term.

I couldn't get in until it got above a dollar to rate it although been watching since .o7/shr.

Probably could of got in lower, but lost track watching others.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

2

Cell Therapeutics, Inc. (CTIC)

Avatar kanstockman (< 20) Submitted: 6/11/07 2:45 PM

2008 a drug in Phase III stage II should be on the market with a half a billion in sales by the 2nd Q. Right now the stock is being dragged down by the sector componants.

Replies: 2 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 49 :   1 2 3 4 5 Next » Jump to page:

Show Pitch Replies

Recs

0

 (CTIC)

Avatar libertybrewcity (< 20) Submitted: 9/03/09 12:59 AM : Outperform Start Price: $1.53 CTIC Score: -56.75

The new drug is about to go into phase 3 and the stock will explode!

Report this Post Replies: 4 | Reply | Permalink

Recs

0

 (CTIC)

Avatar PicoTrader (< 20) Submitted: 9/01/09 3:36 PM : Outperform Start Price: $1.52 CTIC Score: -56.27

cancer drugs in the pipeline with possible good outcomes.....

Report this Post Replies: 0 | Reply | Permalink

Recs

2

 (CTIC)

Avatar dbbfool63 (96.66) Submitted: 8/27/09 6:28 PM : Outperform Start Price: $1.59 CTIC Score: -54.71

Good entry point for mid to long term.

I couldn't get in until it got above a dollar to rate it although been watching since .o7/shr.

Probably could of got in lower, but lost track watching others.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CTIC)

Avatar xnautis (77.40) Submitted: 8/26/09 7:00 PM : Outperform Start Price: $1.59 CTIC Score: -55.85

CTIC has just asked the FDA to approve pixantrone for refractory aggressive non-Hodgkin's lymphoma, a form of cancer. It's still very early in the process but a good long-term bet that if the drug is approved, this will give this stock a significant boost.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CTIC)

Avatar aikiboy2k (62.55) Submitted: 8/26/09 1:23 PM : Outperform Start Price: $1.60 CTIC Score: -56.38

New cancer drug looks like it will be accepted by FDA.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 49 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 1 of 1  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackRodmanRen < 20 01/08/07 Outperform NS $6.96-88.89%-19.17%-69.71

Results 1 - 1 of 1  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD03 312ms